Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Alfaro, Carlos ^a   Suarez, Natalia ^a   Oñate, Carmen ^a   Perez Gracia, Jose L ^b   Martinez Forero, Ivan ^a   Hervas Stubbs, Sandra ^a   Rodriguez, Inmaculada ^a   Perez, Guiomar ^a   Bolaños, Elixabet ^a   Palazon, Asis ^a   de Sanmamed, Miguel Fernandez ^a,b   Morales Kastresana, Aizea ^a   Gonzalez, Alvaro ^b   Melero, Ignacio ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; INTERLEUKIN 8; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CELL INTERACTION; CELL MATURATION; CELL REGENERATION; CELL VIABILITY; CHEMOTAXIS; CROSS PRESENTATION; DENDRITIC CELL; HUMAN; HUMAN CELL; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; T LYMPHOCYTE; TUMOR CELL; ANIMAL; ANTIGEN PRESENTATION; BONE MARROW; CELL SURVIVAL; CYTOLOGY; ESCHERICHIA COLI; IMMUNOLOGY; LYMPH NODE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; BIOLOGICAL TRANSPORT; BONE MARROW; CELL LINE, TUMOR; CELL SURVIVAL; CROSS-PRIMING; DENDRITIC CELLS; ESCHERICHIA COLI; HUMANS; INTERLEUKIN-8; LYMPH NODES; MICE; NEUTROPHILS; OVALBUMIN; PHAGOCYTOSIS; T-LYMPHOCYTES; ULTRAVIOLET RAYS;

EID: 83755194821     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029300     Document Type: Article

References (39)

1. Borregaard N, (2010) Neutrophils, from marrow to microbes. Immunity 33: 657-670.
2. Ley K, Laudanna C, Cybulsky MI, Nourshargh S, (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689.
3. Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, et al. (2010) Neutrophil kinetics in health and disease. Trends Immunol 31: 318-324.
4. Mukaida N, (2000) Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72: 391-398.
5. Waugh DJ, Wilson C, (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14: 6735-6741.
6. Vestweber D, (2007) Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 218: 178-196.
7. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Marie JC, Braut-Boucher F, (2009) p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med 41: 217-225.
8. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535.
9. Steinman RM, (2007) Dendritic cells: understanding immunogenicity. Eur J Immunol 37 (Suppl 1): S53-60.
10. Villadangos JA, Schnorrer P, (2007) Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 7: 543-555.
11. Carbone FR, Heath WR, (2010) Cross-priming: its beginnings. J Immunol 185: 1353-1354.
12. Klechevsky E, Flamar AL, Cao Y, Blanck JP, Liu M, et al. (2010) Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood 116: 1685-1697.
13. Sancho D, Mourao-Sa D, Joffre OP, Schulz O, Rogers NC, et al. (2008) Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest 118: 2098-2110.
14. Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, et al. (2010) Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 207: 1247-1260.
15. Bachem A, Guttler S, Hartung E, Ebstein F, Schaefer M, et al. (2010) Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 207: 1273-1281.
16. Steinman RM, Hawiger D, Nussenzweig MC, (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
17. Granucci F, Foti M, Ricciardi-Castagnoli P, (2005) Dendritic cell biology. Adv Immunol 88: 193-233.
18. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A, (2008) HMGB1: endogenous danger signaling. Mol Med 14: 476-484.
19. MartIn-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, et al. (2003) Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 198: 615-621.
20. van Gisbergen KP, Sanchez-Hernandez M, Geijtenbeek TB, van Kooyk Y, (2005) Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J Exp Med 201: 1281-1292.
21. van Gisbergen KP, Ludwig IS, Geijtenbeek TB, van Kooyk Y, (2005) Interactions of DC-SIGN with Mac-1 and CEACAM1 regulate contact between dendritic cells and neutrophils. FEBS Lett 579: 6159-6168.
22. van Gisbergen KP, Geijtenbeek TB, van Kooyk Y, (2005) Close encounters of neutrophils and DCs. Trends Immunol 26: 626-631.
23. Yang D, de la Rosa G, Tewary P, Oppenheim JJ, (2009) Alarmins link neutrophils and dendritic cells. Trends Immunol 30: 531-537.
24. Beauvillain C, Delneste Y, Scotet M, Peres A, Gascan H, et al. (2007) Neutrophils efficiently cross-prime naive T cells in vivo. Blood 110: 2965-2973.
25. Tewary P, Yang D, de la Rosa G, Li Y, Finn MW, et al. (2010) Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood 116: 3465-3474.
26. Soehnlein O, (2009) An elegant defense: how neutrophils shape the immune response. Trends Immunol 30: 511-512.
27. Alfaro C, Suarez N, Martinez-Forero I, Palazon A, Rouzaut A, et al. (2011) Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation. PLoS One 6: e17922.
28. Mazzolini G, Alfaro C, Sangro B, Feijoo E, Ruiz J, et al. (2005) Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas. J Clin Oncol 23: 999-1010.
29. Alfaro C, Suarez N, Gonzalez A, Solano S, Erro L, et al. (2009) Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Br J Cancer 100: 1111-1119.
30. Tirapu I, Arina A, Mazzolini G, Duarte M, Alfaro C, et al. (2004) Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens. Int J Cancer 110: 51-60.
31. Murillo O, Dubrot J, Palazon A, Arina A, Azpilikueta A, et al. (2009) In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb. Eur J Immunol 39: 2424-2436.
32. Feijoo E, Alfaro C, Mazzolini G, Serra P, Penuelas I, et al. (2005) Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int J Cancer 116: 275-281.
33. Hoffmann TK, Meidenbauer N, Dworacki G, Kanaya H, Whiteside TL, (2000) Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res 60: 3542-3549.
34. Rouzaut A, Garasa S, Teijeira A, Gonzalez I, Martinez-Forero I, et al. (2010) Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-alpha. Eur J Immunol 40: 3054-3063.
35. Janeway CA Jr, Medzhitov R, (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216.
36. Steinman RM, Hawiger D, Liu K, Bonifaz L, Bonnyay D, et al. (2003) Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann N Y Acad Sci 987: 15-25.
37. Steinman RM, Banchereau J, (2007) Taking dendritic cells into medicine. Nature 449: 419-426.
38. Culshaw S, Millington OR, Brewer JM, McInnes IB, (2008) Murine neutrophils present Class II restricted antigen. Immunol Lett 118: 49-54.
39. Yang CW, Strong BS, Miller MJ, Unanue ER, (2010) Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J Immunol 185: 2927-2934.